Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Wilson, Nicola K
Oram, S Helen
Janes, Mary E
Donaldson, Ian J
Follows, George A
AffiliationDepartment of Haematology, Cambridge Institute for Medical Research, Cambridge University, Cambridge, United Kingdom.
MetadataShow full item record
AbstractThe Lmo2 gene encodes a transcriptional cofactor critical for the development of hematopoietic stem cells. Ectopic LMO2 expression causes leukemia in T-cell acute lymphoblastic leukemia (T-ALL) patients and severe combined immunodeficiency patients undergoing retroviral gene therapy. Tightly controlled Lmo2 expression is therefore essential, yet no comprehensive analysis of Lmo2 regulation has been published so far. By comparative genomics, we identified 17 highly conserved noncoding elements, 9 of which revealed specific acetylation marks in chromatin-immunoprecipitation and microarray (ChIP-chip) assays performed across 250 kb of the Lmo2 locus in 11 cell types covering different stages of hematopoietic differentiation. All candidate regulatory regions were tested in transgenic mice. An extended LMO2 proximal promoter fragment displayed strong endothelial activity, while the distal promoter showed weak forebrain activity. Eight of the 15 distal candidate elements functioned as enhancers, which together recapitulated the full expression pattern of Lmo2, directing expression to endothelium, hematopoietic cells, tail, and forebrain. Interestingly, distinct combinations of specific distal regulatory elements were required to extend endothelial activity of the LMO2 promoter to yolk sac or fetal liver hematopoietic cells. Finally, Sfpi1/Pu.1, Fli1, Gata2, Tal1/Scl, and Lmo2 were shown to bind to and transactivate Lmo2 hematopoietic enhancers, thus identifying key upstream regulators and positioning Lmo2 within hematopoietic regulatory networks.
CitationExpression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors. 2009, 113 (23):5783-92 Blood
- A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
- Authors: Draheim KM, Hermance N, Yang Y, Arous E, Calvo J, Kelliher MA
- Issue date: 2011 Mar 10
- Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells.
- Authors: Landry JR, Kinston S, Knezevic K, Donaldson IJ, Green AR, Göttgens B
- Issue date: 2005 Oct 15
- Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
- Authors: El Omari K, Hoosdally SJ, Tuladhar K, Karia D, Vyas P, Patient R, Porcher C, Mancini EJ
- Issue date: 2011 Feb 17
- Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
- Authors: Landry JR, Kinston S, Knezevic K, de Bruijn MF, Wilson N, Nottingham WT, Peitz M, Edenhofer F, Pimanda JE, Ottersbach K, Göttgens B
- Issue date: 2008 Mar 15
- A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
- Authors: Oram SH, Thoms JA, Pridans C, Janes ME, Kinston SJ, Anand S, Landry JR, Lock RB, Jayaraman PS, Huntly BJ, Pimanda JE, Göttgens B
- Issue date: 2010 Oct 28